Saturday, July 11, 2026

pharma · Psoriasis · EGFR Positive Non-small Cell Lung Cancer

Betta Pharmaceuticals Co

Betta Pharmaceuticals Co clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Hangzhou, CN HQ
23 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hangzhou, CN
Employees
23
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Programs

Betta Pharmaceuticals Co projects

1 ClinicalTrials.gov programs sponsored by Betta Pharmaceuticals Co.

Betta Pharmaceuticals Co has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 1% icotinib hydrochloride cream

    Betta Pharmaceuticals Co.,

    Psoriasis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Betta Pharmaceuticals Co have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.